IO Biotech, Inc. IOBTQ
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $3.5M
- P/E
- 0.0×
Follow IOBTQ
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
3.33 | 2.32 | 1.96 | 2.01 |
Net Debt/EBITDA |
2.23 | 1.65 | 0.93 | 0.73 | |
Debt/Assets |
0.00% | 0.00% | 15.88% | 41.71% | |
Debt/Equity |
0.00 | 0.00 | 4.22 | 18.29 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.63 | 1.03 | 0.76 | 2.21 | |
Capex/Depreciation |
(0.17) | (0.46) | (0.41) | (0.07) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.30) | (0.35) | (0.30) | (0.28) | |
Cash per Share |
0.91 | 0.56 | 0.43 | 0.46 | |
Shareholders Equity per Share |
0.71 | 0.40 | 0.02 | 0.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.71 | 0.40 | 0.02 | 0.01 | |
Free Cash Flow |
(19.64) | (23.10) | (19.85) | (18.48) | |
Working Capital |
45.47 | 24.06 | 19.08 | 18.52 | |
Capital Expenditures |
(0.01) | (0.03) | (0.03) | 0.00 | |
Net Current Asset Value |
44.27 | 23.03 | (1.75) | (2.21) | |
| Other line items | |||||
Quick Ratio |
3.08 | 2.03 | 1.41 | 1.67 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.30) | (0.35) | (0.30) | (0.28) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
4.27 | 4.52 | 5.28 | 5.42 | |
Average Assets |
109.21 | 86.95 | 76.90 | 64.95 | |
Average Common Equity |
90.09 | 70.94 | 48.93 | 36.74 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates